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repeat region and nonhomologous recombination of other sequences accounted for the heterogeneity of the BamHI H fragments. PCR amplification from additional HLP specimens detected similar recombinant variants. A possible example of site-specific recombination joining the BamHI Y portion of the EBNA-2 gene to sequences within the BamHI S fragment was also detected in multiple HLP specimens. These data indicate that intrastrain recombination during productive replication confounds the use of restriction fragment length polymorphism analysis of the BamHI Y and H fragments to identify EBV strains in HLP. In patients with permissive epithelial EBV infections, EBV strains could be more accurately distinguished by sequence identity or divergence within known regions of genetic strain variation.
Oral hairy leukoplakia (HLP), a lesion occurring on the lateral borders of the tongue in many patients infected with the human immunodeficiency virus, is caused by the productive replication of the Epstein-Barr virus (EBV) within mucosal epithelial cells (23) . Some HLP lesions are coinfected with both EBV type 1 (EBV-1) and EBV-2, on the basis of typing of the Epstein-Barr nuclear antigen 2 (EBNA-2) gene, and some HLP lesions may be coinfected with multiple strains of the same EBV type (55) . During productive replication, the EBV in HLP apparently recombines within the BamHI WYH region, including the EBNA-2 gene, to generate viral variants that are capable of replicating efficiently and persisting within the lesion over time (55) .
The EBV strains in lymphoblastoid cell lines (LCLs) can be differentiated by BamHI H fragment size (6, 24) , which differs among strains in the number of 125-bp repeat units within the IR2 internal repeat region. Based on these observations in LCLs, restriction fragment length polymorphism analysis of the BamHI H fragment has been used as a marker of EBV strain identity and coinfection in studies of natural infections in patients. In HLP, multiple fragments hybridize to probes containing sequences from the BamHI H portion of the EBNA-2 gene in the size range of 4.5 to 12 kb (55) . These heterogeneous BamHI H fragments could represent coinfection of HLP with different, genetically stable EBV strains, or they could represent recombinant viral variants that differ in the number of repeat units within IR2 (55) . However, it was difficult to attribute the large size of some of the BamHI H fragments in HLP (8 to 12 kb) only to IR2 variation, suggesting that additional rearrangements may have occurred elsewhere in the fragment.
The present study was designed to investigate the origin of the BamHI H fragment heterogeneity in HLP by identifying and characterizing the EBV strains and recombinant variants present in clones from a single HLP specimen containing multiple BamHI H fragments. Restriction mapping and sequence analysis of four clones demonstrated that multiple viral variants were generated through recombination within the BamHI Y and H regions of a single EBV strain. Although an HLP lesion may be coinfected with multiple EBV types and strains, numerous variants of EBV arise through intrastrain recombination during productive viral replication, accounting for much of the restriction fragment heterogeneity of the BamHI Y and H fragments.
MATERUILS AND METHODS
Cloning of HLP DNA. HLP biopsy specimens were obtained from human immunodeficiency virus-seropositive, volunteer patients, and the DNA was extracted as described elsewhere (18, 43 (55) . Probe H was derived from the subcloned BamHI H fragment of B95-8 digested with NotI and synthesized from the right end of the fragment. The hybridization domains of these probes are illustrated in Fig. 1 EBV strain identification. To identify the EBV strains represented, the sequences of the EBNA-2 genes were determined for clones 1 to 3. All three clones contained identical EBNA-2 sequences, indicating that a single EBV strain was the source of the variants; thus, the BamHI H fragment heterogeneity in this HLP developed through intrastrain recombination. The HLP EBNA-2 sequence was similar to that of W91 and distinct from that of B95-8, the two prototype EBV-1 LCL strains (Table 2) (11, 13) . The HLP EBNA-2 sequence contained a 24-bp deletion of sequence from the polyproline region, a 3-bp insertion, and a 3-bp deletion of sequence, each preserving the open reading frame of the gene. Single-nucleotide substitutions usually resulted in conservative or similar amino acid changes in the predicted protein sequence ( Table  2 ). The sequence changes in the HLP EBNA-2 gene would not disrupt the known EBNA-2 functional domains involved in transcriptional transactivation and B-lymphocyte growth transformation (11 (Fig. 4) . Replicates of each digest were hybridized to probes 2A-H, IR2, and H (Fig. 1) . Each of the three enzyme digestions generated subfragmrents of the three clones that were compared with those of the B95-8 BamHI H fragment (Fig. 4) The BamHI H fragments of clones 1 to 3 each lost the BsaMI site in BHLF1 to the right of IR2 but differed in the number of repeat units within IR2 (Fig. 5 and 6) . Therefore, the unique DNA sequences from U2 and U3 immediately surrounding IR2 were examined in the three clones. In clone 2, the second ladder of 2.9-to 4.7-kb fragments contained 15 bands, indicating a total of 16 copies in both IR2 regions in this clone. In clone 3, the second ladder of 2.9-to 5.8-kb fragments contained 23 bands, indicating a total of 24 copies in both IR2 regions in this clone. recombinations in clones 2 and 3 took place at a 7-bp sequence of homology between the two sites: CTGGGGC. These data indicated that homologous recombination of the IR2 sequences may also include nearby unique sequences and suggested that some degree of site specificity is involved.
To further evaluate variation among clones 1 to 3, the sequences of the partially duplicated EBNA-2 genes from clones 2 and 3 were examined. Codon 472 (GAA) that had been deleted from the complete EBNA-2 sequences of clones 1 to 3 ( Table 2 ) was present in the partially duplicated EBNA-2 sequences of clones 2 and 3. Thus, the deletion of codon 472 represented another intrastrain recombination event that occurred independently of the U3-EBNA-2 recombination and the deletions at the IR2-U3 junction. These structural and sequence variations among clones 1 to 3 (Fig. 7) indicated that a complex series of recombination events gave rise to several different intrastrain viral variants, accounting for much of the BamHI H-fragment heterogeneity in this HLP. other HLP samples, PCR primers that flanked the U3-EBNA-2 junction site were chosen. Amplification of DNA from clone 2, and from the original HLP specimen from which clone 2 was obtained, generated the predicted product size of 442 bp (Fig. 8) . HLP specimens from several additional patients were examined by PCR amplification with these primers. Notably, the PCR products detected in these HLP specimens ranged in size from 442 to 1,600 bp (Fig. 8) region. The EBNA-2 sequence in clone 4 matched identically with that in clones 1 to 3. Thus, clone 4 represented another variant of the same original strain, arising through recombination within the HLP lesion. The recombination took place within the polyproline region of the EBNA-2 gene, with bp 48737 of EBNA-2 linked to bp 85777 of BamHI-S (Fig. 9) . Similar to the IR2-U3 recombinations, this recombination site also shared an 8-bp sequence homology between BamHI-Y and BamHI-S: CTCCACCA. As a result of this recombination, the EBNA-2 open reading frame was truncated by a stop codon 24 bp beyond the recombination site. The BSLF1 gene was also truncated by a stop codon in BamHI-Y, preserving less than half of its potential amino acid sequence (Fig. 9 ).
An RNA probe synthesized from the entire insert of clone 4 was hybridized by Southern blot back to the HLP DNA from which it was cloned. Both the standard BamHI Y and BamHI S fragments were easily detected by this probe, but a 2.2-kb fragment was not detected (data not shown), indicating a low copy number of the EBNA-2-BamHI-S recombinant molecule within the HLP lesion.
To determine if this EBNA-2-BamHI-S recombination had occurred in other HLP lesions, PCR primers that flanked the EBNA-2-BamHI-S junction site were chosen. Amplification of DNA from clone 4, and from the original HLP lesion from which clone 4 was obtained, generated the predicted product size of 477 bp (Fig. 10) . PCR (Fig. 10 and data not shown) . The products hybridized with both probes 2A-Y and S. In three cases, the EBNA-2-BamHI-S variants were detected in sequential HLP biopsy specimens from the same patient ( Fig. 10 and data [one 2 contained 10 and 6 copies, while
However, homologous recombination within repetitive se-)pies. quences frequently generates variation (3, 38) , and homolo- gous recombination in EBV is closely linked with productive replication (54) . In the present study of HLP, homologous recombination within the IR2 sequences contributed to the size variation of the BamHI H fragment, indicating that BamHI-H variation does not actually distinguish strains. Similarly, repetitive sequences within the latent membrane protein 1 gene recombine during replication in HLP to generate intrastrain variation (41) . By analogy, other repetitive sequences within the BamHI K and Bi fragments and the EBNA genes may also experience intrastrain homologous recombination (55) . Thus, in HLP, intrastrain recombination would obscure the identification of EBV strains based on variation in these fragments or gene products. Even without HLP, immunocompromised patients demonstrate continuous, high-level EBV replication and shedding of virions in the oropharynx (2, 8, 52) . Given this degree of viral replication, homologous recombination could produce EBV intrastrain variation in these patients as well. Thus, in permissive epithelial infections of immunocompromised patients, EBV strains could be more accurately distinguished by sequence identity or divergence within known regions of genetic strain variation, such as the EBNA-2 or latent membrane protein 1 gene (11, 41) .
In the present study, variation of the 125-bp repeat units in IR2 resulted from unequal pairing of homologous DNA strands with subsequent crossover recombination. However, the recombination events at the IR2-U3 junction involved short (7- quences with other regions of the herpes simplex type genome having short sequence homologies of 10 to 12 bp have been previously described (29, 42) . A similar illegitimate mechanism may account for the two different IR2-U3 deletion patterns demonstrated for clone 1 (225 bp) and clones 2 and 3 (117 bp).
The EBNA-2-BamHI-S recombination also involved an 8-bp sequence homology at the recombination site. However, the independent occurrence of this specific recombination in multiple HLP specimens suggests a site-specifically mediated recombination mechanism. The CTCCACCA recombination site shares features with many of the published recombination recognition sequences of prokaryotic and eukaryotic systems, including an 8-bp length and a high G+C content (15) .
The P3HR-1 cell line, originally selected for high virus production, is an example in which nonhomologous recombination between normally distant regions of the EBV genome generated defective molecules in lymphocytes (9, 39) . These molecules, which include juxtapositions of BamHI-W with BamHI-Z (WZhet), have been shown to be responsible for the unusual biologic properties of the P3HR-1 strain (40) . The exact sequences involved at most of the P3HR-1 recombination sites have not been determined. However, the data presented here indicate that nonhomologous, non-site-specific recombination frequently occurs between nonrepetitive DNA sequences during EBV replication in vivo. Similar to the U3-EBNA-2 recombinations, WZhet DNA and deletions of the EBNA-2 gene detected in HLP specimens also demonstrate variability in their sites of nonhomologous recombination (26, 43, 51) .
In addition to the presence of defective genomes, the P3HR-1 strain is also deleted for the EBNA-2 gene, and viral (51, 55) . EBNA-2 is an important regulatory gene early in B-lymphocyte infection and is essential for B-lymphocyte transformation (11, 44) . Thus, the viral variants with the EBNA-2-BamHI-S recombination would be incapable of establishing latency and immortalizing B lymphocytes (10, 11, 31, 32) . The role of EBNA-2 in epithelial infection is less clear. Latently infected nasopharyngeal carcinoma cells do not express EBNA-2 (57), and EBNA-2 is not required for productive replication in the oropharynx (51) . It is unclear whether the EBNA-2 gene product is expressed in HLP (47, 53) . However, the prevalence and persistence of the EBNA-2-BamHI-S recombinant and other EBNA-2-defective variants in HLP (51, 55) suggest a selective advantage for these viral variants in a permissive environment. Thus, the role of the defective variants in the pathogenesis of HLP merits further investigation.
